Total Payments
$1,909
2024 Payments
$24.83
Companies
14
Transactions
43
Medicare Patients
164
Medicare Billing
$31,846
Payment Breakdown by Category
Other$697.90 (36.6%)
Food & Beverage$654.11 (34.3%)
Consulting$300.00 (15.7%)
Education$256.94 (13.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Long term medical supply or device loan | $697.90 | 7 | 36.6% |
| Food and Beverage | $654.11 | 32 | 34.3% |
| Consulting Fee | $300.00 | 1 | 15.7% |
| Education | $256.94 | 3 | 13.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $840.89 | 15 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $300.00 | 1 | $0 (2021) |
| Seagen Inc. | $156.99 | 2 | $0 (2023) |
| Janssen Biotech, Inc. | $129.62 | 2 | $0 (2023) |
| Genentech USA, Inc. | $121.82 | 7 | $0 (2023) |
| Daiichi Sankyo Inc. | $101.05 | 4 | $0 (2023) |
| Merck Sharp & Dohme LLC | $74.61 | 4 | $0 (2023) |
| Celgene Corporation | $45.63 | 2 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $24.83 | 1 | $0 (2024) |
| AVEO Pharmaceuticals, Inc. | $24.37 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $24.83 | 1 | AstraZeneca Pharmaceuticals LP ($24.83) |
| 2023 | $830.30 | 17 | Novartis Pharmaceuticals Corporation ($329.04) |
| 2022 | $563.45 | 13 | Novartis Pharmaceuticals Corporation ($511.85) |
| 2021 | $362.56 | 4 | E.R. Squibb & Sons, L.L.C. ($300.00) |
| 2020 | $47.46 | 2 | Daiichi Sankyo Inc. ($24.38) |
| 2019 | $39.55 | 3 | Genentech USA, Inc. ($27.15) |
| 2018 | $13.60 | 1 | Genentech USA, Inc. ($13.60) |
| 2017 | $27.20 | 2 | Genentech USA, Inc. ($27.20) |
All Payment Transactions
43 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/01/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: Oncology | ||||||
| 11/03/2023 | Genentech USA, Inc. | Phesgo (Biological) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: BioOncology | ||||||
| 07/26/2023 | Seagen Inc. | — | Education | In-kind items and services | $99.00 | General |
| 07/26/2023 | Seagen Inc. | — | Education | In-kind items and services | $57.99 | General |
| 06/29/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: HORMONE THERAPY | ||||||
| 06/16/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: ONCOLOGY | ||||||
| 06/15/2023 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: Oncology | ||||||
| 06/09/2023 | AVEO Pharmaceuticals, Inc. | FOTIVDA (Drug) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: Oncology | ||||||
| 06/07/2023 | Novartis Pharmaceuticals Corporation | PIQRAY (Drug), KISQALI | Food and Beverage | In-kind items and services | $29.94 | General |
| Category: Oncology | ||||||
| 06/01/2023 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: ONCOLOGY | ||||||
| 05/31/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | — | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| 05/25/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Education | In-kind items and services | $99.95 | General |
| Category: Oncology | ||||||
| 05/25/2023 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $23.35 | General |
| Category: Hematology | ||||||
| 05/16/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $29.67 | General |
| Category: Oncology | ||||||
| 05/03/2023 | Genentech USA, Inc. | Phesgo (Biological) | Food and Beverage | In-kind items and services | $32.12 | General |
| Category: BioOncology | ||||||
| 02/15/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | — | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| 01/19/2023 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $28.28 | General |
| Category: ONCOLOGY | ||||||
| 01/14/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | — | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| 12/15/2022 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: ONCOLOGY | ||||||
| 11/18/2022 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: ONCOLOGY | ||||||
| 10/06/2022 | Novartis Pharmaceuticals Corporation | KISQALI (Drug), FEMARA | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: ONCOLOGY | ||||||
| 09/29/2022 | Daiichi Sankyo Inc. | ENHERTU (Drug) | Food and Beverage | In-kind items and services | $29.32 | General |
| Category: ONCOLOGY | ||||||
| 08/26/2022 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: ONCOLOGY | ||||||
| 08/16/2022 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: ONCOLOGY | ||||||
| 06/22/2022 | Novartis Pharmaceuticals Corporation | KISQALI (Drug), FEMARA | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 34 | 69 | $21,540 | $6,297 |
| 2022 | 2 | 39 | 88 | $34,428 | $10,042 |
| 2021 | 2 | 37 | 72 | $28,009 | $8,827 |
| 2020 | 3 | 54 | 95 | $22,659 | $6,680 |
Total Patients
164
Total Services
324
Medicare Billing
$31,846
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 23 | 54 | $15,282 | $4,404 | 28.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 11 | 15 | $6,258 | $1,893 | 30.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 22 | 62 | $26,914 | $7,730 | 28.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 17 | 26 | $7,514 | $2,312 | 30.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 18 | 50 | $21,520 | $6,708 | 31.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 19 | 22 | $6,489 | $2,119 | 32.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 26 | 58 | $13,478 | $3,856 | 28.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 11 | 20 | $6,580 | $2,030 | 30.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 17 | 17 | $2,601 | $793.89 | 30.5% |
About Dr. Caroline Hwang, MD
Dr. Caroline Hwang, MD is a Hematology & Oncology healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/14/2007. The National Provider Identifier (NPI) number assigned to this provider is 1811102718.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Caroline Hwang, MD has received a total of $1,909 in payments from pharmaceutical and medical device companies, with $24.83 received in 2024. These payments were reported across 43 transactions from 14 companies. The most common payment nature is "Long term medical supply or device loan" ($697.90).
As a Medicare-enrolled provider, Hwang has provided services to 164 Medicare beneficiaries, totaling 324 services with total Medicare billing of $31,846. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Bronx, NY
- Active Since 05/14/2007
- Last Updated 07/08/2007
- Taxonomy Code 207RH0003X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1811102718
Products in Payments
- KISQALI (Drug) $450.96
- ERLEADA (Drug) $129.62
- KEYTRUDA (Biological) $74.61
- Enhertu (Drug) $71.73
- MEKINIST (Drug) $60.89
- Phesgo (Biological) $53.87
- Perjeta (Biological) $43.74
- PIQRAY (Drug) $29.94
- ENHERTU (Drug) $29.32
- LYNPARZA (Drug) $24.83
- FOTIVDA (Drug) $24.37
- Xtandi (Drug) $23.61
- Pomalyst (Drug) $23.35
- ORGOVYX (Drug) $22.32
- ZEPOSIA (Drug) $22.28
- IBRANCE (Drug) $20.13
- Kadcyla (Biological) $12.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Bronx
Dr. Mark Chaitowitz, Md, MD
Hematology & Oncology — Payments: $13,776
Hematology & Oncology $13,776
Stuart Packer, Md, MD
Hematology & Oncology — Payments: $13,717
Hematology & Oncology $13,717
Mr. Howard Bruckner, M.d, M.D
Hematology & Oncology — Payments: $12,939
Hematology & Oncology $12,939
Dr. Avi Retter, Md, MD
Hematology & Oncology — Payments: $11,928
Hematology & Oncology $11,928
Dr. Ilmana Fulger, Md, MD
Hematology & Oncology — Payments: $9,395
Hematology & Oncology $9,395
Dr. Ivette Vigoda, Md, MD
Hematology & Oncology — Payments: $8,453
Hematology & Oncology $8,453